Global Artemisinic Acid Market Size, Trends & Growth Opportunity, By Type (Antimalarial Injections, Antimalarial Tablets), By Region and Forecast till 2030.
Global Artemisinic Acid Market
The global Artemisinic Acid market was valued at USD 730.57 million in 2022 which expected to reach USD 975.05 million by 2030 at a CAGR 3.63% from 2023-2030.
Artemisinic acid, an amorphane sesquiterpene derived from Artemisia annua L., is isolated. Artemisinic acid, while less effective than artemisinin, has a wide range of pharmacological activity, including antimalarial activity, anti-tumor activity, antipyretic effect, antibacterial activity, allelopathy effect, and anti-adipogenesis effect.
Public organizations from all over the world have taken steps to increase access to efficient malaria treatment in an effort to reduce the number of fatalities brought on by the illness. For instance, the WHO sought to ensure access to malaria diagnosis, prevention, and treatments as part of universal health coverage in 2021 as part of the Malaria Elimination initiative. It is anticipated that such public health organization initiatives to offer affordable treatment will increase demand for drugs like artemisinin acid and thereby foster market expansion.
COVID-19 Impact on the Artemisinic Acid Market
The COVID-19 pandemic had a negative impact on malaria treatment demand because those affected by COVID-19 were given treatment preference. In March 2020. The WHO urged African countries with a high rate of malaria cases to continue providing malaria services such as detection, treatment, and prevention. This is likely to have boosted the market during the pandemic period.
Market Segmentation
The Global Artemisinic Acid Market is segmented into Type. By Type such as Antimalarial Injections, Antimalarial Tablets. Tablets are a form of oral drug administration. Tablets are self-administering and do not require a trained physician for drug administration, which is one of the primary reasons for their widespread acceptance. Furthermore, tablet formulations provide high patient compliance, accurate dosing, drug release control, and stability. This increases the market demand for antimalarial tablet formulations.
Regional Analysis
Global Artemisinic Acid Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Middle East & Africa dominated the Artemisinic Acid market. The regional market is expected to grow at the fastest rate of 4.31% over the forecast period. Africa is one of the major malaria-affected regions on the continent. According to UNICEF, a child under the age of five dies from malaria in Africa every minute. Public organizations in MEA are eager to provide treatment in order to reduce the number of deaths associated with the disease. For instance, the WHO stated in 2021 that the African Region of the WHO accounts for a significant portion of the global malaria burden. In 2021, the region was responsible for 95% of malaria cases and 96% of malaria deaths. The high disease burden and public-sector initiatives to raise awareness about malaria treatment are assisting in the growth of the regional market.
Key Players
Various key players are listed in this report such as Sanofi, KPC Pharmaceuticals, Inc, Guilin Pharmaceutical Co., Ltd, Calyx Chemicals and Pharmaceuticals Ltd., Novartis AG, Ipca Laboratories Ltd., Cipla Inc, Shin Poong Pharm Co., Ltd., Rupus Global Limited, AdvacarePharma.
Market Taxonomy
By Type
• Antimalarial Injections
• Antimalarial Tablets
By Region
• North America
• Latin America
• Europe
• China
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Artemisinic Acid Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Artemisinic Acid Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Artemisinic Acid Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Artemisinic Acid Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Artemisinic Acid Market Share Analysis, By Type
5.3 Global Artemisinic Acid Market Size and Forecast, By Type
5.3.1 Antimalarial Injections
5.3.2 Antimalarial Tablets
6 Global Artemisinic Acid Market, By Region
6.1 Global Artemisinic Acid Market Share Analysis, By Region
6.2 Global Artemisinic Acid Market Share Analysis, By Region
6.3 Global Artemisinic Acid Market Size and Forecast, By Region
7 North America Artemisinic Acid Market Analysis and Forecast (2023-2030)
7.1 Introduction
7.2 North America Artemisinic Acid Market Share Analysis, By Type
7.3 North America Artemisinic Acid Market Size and Forecast, By Application
7.4 North America Artemisinic Acid Market Size and Forecast, By Country
7.5.1 U.S.
7.6.2 Canada
7.7.3 Mexico
8 Europe Artemisinic Acid Market Analysis and Forecast (2023-2030)
8.1 Introduction
8.2 Europe Artemisinic Acid Market Share Analysis, By Type
8.3 Europe Artemisinic Acid Market Size and Forecast, By Application
8.4 Europe Artemisinic Acid Market Size and Forecast, By Country
8.5.1 Germany
8.6.2 France
8.7.3 UK
8.8.4. Rest of Europe
9 Asia Pacific Artemisinic Acid Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 Asia Pacific Artemisinic Acid Market Share Analysis, By Type
9.3 Asia Pacific Artemisinic Acid Market Size and Forecast, By Application
9.4 Asia Pacific Artemisinic Acid Market Size and Forecast, By Country
9.5.1 China
9.6.2 Japan
9.7.3 India
9.8.4. Rest of Asia Pacific
10 Latin America Artemisinic Acid Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Latin America Artemisinic Acid Market Share Analysis, By Type
10.3 Latin America Artemisinic Acid Market Size and Forecast, By Application
10.4 Latin America Artemisinic Acid Market Size and Forecast, Country
10.5.1. Brazil
10.6.2. Rest of Latin America
11 Middle East Artemisinic Acid Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Middle East Artemisinic Acid Market Share Analysis, By Type
11.3 Middle East Artemisinic Acid Market Size and Forecast, By Application
11.4 Middle East Artemisinic Acid Market Size and Forecast, By Country
11.5.1. Saudi Arabia
11.6.2. UAE
11.7.3. Egypt
11.8.4. Kuwait
11.9.5. South Africa
12 Competitive Analysis
12.1 Competition Dashboard
12.2 Market share Analysis of Top Vendors
12.3 Key Development Strategies
13 Company Profiles
13.1 Sanofi
13.1.1 Overview
13.1.2 Offerings
13.1.3 Key Financials
13.1.4 Business Segment & Geographic Overview
13.1.5 Key Market Developments
13.1.6 Key Strategies
13.2. KPC Pharmaceuticals, Inc
13.2.1 Overview
13.2.2 Offerings
13.2.3 Key Financials
13.2.4 Business Segment & Geographic Overview
13.2.5 Key Market Developments
13.2.6 Key Strategies
13.3. Guilin Pharmaceutical Co., Ltd
13.3.1 Overview
13.3.2 Offerings
13.3.3 Key Financials
13.3.4 Business Segment & Geographic Overview
13.3.5 Key Market Developments
13.3.6 Key Strategies
13.4 Calyx Chemicals and Pharmaceuticals Ltd.
13.4.1 Overview
13.4.2 Offerings
13.4.3 Key Financials
13.4.4 Business Segment & Geographic Overview
13.4.5 Key Market Developments
13.4.6 Key Strategies
13.5 Novartis AG.
13.5.1 Overview
13.5.2 Offerings
13.5.3 Key Financials
13.5.4 Business Segment & Geographic Overview
13.5.5 Key Market Developments
13.5.6 Key Strategies
13.6 Ipca Laboratories Ltd.
13.6.1 Overview
13.6.2 Offerings
13.6.3 Key Financials
13.6.4 Business Segment & Geographic Overview
13.6.5 Key Market Developments
13.6.6 Key Strategies
13.7 Cipla Inc
13.7.1 Overview
13.7.2 Offerings
13.7.3 Key Financials
13.7.4 Business Segment & Geographic Overview
13.7.5 Key Market Developments
13.7.6 Key Strategies
13.8 Shin Poong Pharm Co., Ltd.
13.8.1 Overview
13.8.2 Offerings
13.8.3 Key Financials
13.8.4 Business Segment & Geographic Overview
13.8.5 Key Market Developments
13.8.6 Key Strategies
13.9 Rupus Global Limited
13.9.1 Overview
13.9.2 Offerings
13.9.3 Key Financials
13.9.4 Business Segment & Geographic Overview
13.9.5 Key Market Developments
13.9.6 Key Strategies
